Activity of three β-lactams (ertapenem, meropenem and ampicillin) against intraphagocytic Listeria monocytogenes and Staphylococcus aureus

Journal of Antimicrobial Chemotherapy

Volumn 55, Issue 6, 2005, Pages 897-904

  Lemaire, Sandrine ^a   Van Bambeke, Françoise ^a   Mingeot Leclercq, Marie Paule ^a   Tulkens, Paul M ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

Ampicillin; Ertapenem; L. monocytogenes; Meropenem; S. aureus; THP 1 macrophages

Indexed keywords

AMPICILLIN; BETA LACTAM ANTIBIOTIC; ERTAPENEM; GENTAMICIN; MEROPENEM; OXYTETRACYCLINE;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIOLYSIS; BACTERIOSTASIS; CELLULAR DISTRIBUTION; COLONY FORMING UNIT; CONCENTRATION (PARAMETERS); DRUG ACCUMULATION; DRUG EFFICACY; DRUG HALF LIFE; DRUG POTENCY; DRUG PROTEIN BINDING; DRUG STABILITY; ELECTRON MICROSCOPY; EQUILIBRIUM DIALYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INCUBATION TIME; LISTERIA MONOCYTOGENES; MACROPHAGE; MINIMUM INHIBITORY CONCENTRATION; PHAGOCYTOSIS; QUANTITATIVE ANALYSIS; SERUM BACTERICIDAL ACTIVITY; STAPHYLOCOCCUS AUREUS;

AMPICILLIN; ANTI-BACTERIAL AGENTS; BETA-LACTAMS; BLOOD BACTERICIDAL ACTIVITY; DOSE-RESPONSE RELATIONSHIP, DRUG; LACTAMS; LISTERIA MONOCYTOGENES; MICROBIAL SENSITIVITY TESTS; STAPHYLOCOCCUS AUREUS; THIENAMYCINS;

EID: 21244444295     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dki094     Document Type: Article

References (36)

1. Tulkens, P. M. (1991). Intracellular distribution and activity of antibiotics. European Journal of Clinical Microbiology and Infectious Diseases 10, 100-6.
2. Carryn, S., Chanteux, H., Seral, C. et al. (2003). Intracellular pharmacodynamics of antibiotics. Infectious Disease Clinics of North America 17, 615-34.
3. Bortolussi, R., Vandenbroucke-Grauls, C. M., van Asbeck, B. S. et al. (1987). Relationship of bacterial growth phase to killing of Listeria monocytogenes by oxidative agents generated by neutrophils and enzyme systems. Infection and Immunity 55, 3197-203.
4. Krut, O., Sommer, H. & Kronke, M. (2004). Antibiotic-induced persistence of cytotoxic Staphylococcus aureus in non-phagocytic cells. Journal of Antimicrobial Chemotherapy 53, 167-73.
5. Hof, H. (2004). An update on the medical management of listeriosis. Expert Opinion in Pharmacotherapy 5, 1727-35.
6. Nairn, K., Shepherd, G. L. & Edwards, J. R. (1995). Efficacy of meropenem in experimental meningitis. Journal of Antimicrobial Chemotherapy 36, Suppl. A, 73-84.
7. Malanoski, G. J., Samore, M. H., Pefanis, A. et al. (1995). Staphylococcus aureus catheter-associated bacteremia. Minimal effective therapy and unusual infectious complications associated with arterial sheath catheters. Archives of Internal Medicine 155, 1161-6.
8. Rivero, G. A., Torres, H. A., Rolston, K. V. et al. (2003). Listeria monocytogenes infection in patients with cancer. Diagnostic Microbiology and Infectious Disease 47, 393-8.
9. Livermore, D. M., Sefton, A. M. & Scott, G. M. (2003). Properties and potential of ertapenem. Journal of Antimicrobial Chemotherapy 52, 331-44.
10. Cunha, B. A. (2002). Ertapenem. A review of its microbiologic, pharmacokinetic and clinical aspects. Drugs Today (Barcelona) 38, 195-213.
11. Scorneaux, B., Ouadrhiri, Y., Anzalone, G. et al. (1996). Effect of recombinant human gamma interferon on intracellular activities of antibiotics against Listeria monocytogenes in the human macrophage cell line THP-1. Antimicrobial Agents and Chemotherapy 40, 1225-30.
12. Carryn, S., Van Bambeke, F., Mingeot-Leclercq, M. P. et al. (2002). Comparative intracellular (THP-1 macrophage) and extracellular activities of β-lactams, azithromycin, gentamicin, and fluoroquinolones against Listeria monocytogenes at clinically relevant concentrations. Antimicrobial Agents and Chemotherapy 46, 2095-103.
13. Carryn, S., Van Bambeke, F., Mingeot-Leclercq, M. P. et al. (2003). Activity of β-lactams (ampicillin, meropenem), gentamicin, azithromycin and moxifloxacin against intracellular Listeria monocytogenes in a 24h THP-1 human macrophage model. Journal of Antimicrobial Chemotherapy 51, 1051-2.
14. Seral, C., Van Bambeke, F. & Tulkens, P. M. (2003). Quantitative analysis of gentamicin, azithromycin, telithromycin, ciprofloxacin, moxifloxacin, and oritavancin (LY333328) activities against intracellular Staphylococcus aureus in mouse J774 macrophages. Antimicrobial Agents and Chemotherapy 47, 2283-92.
15. Tsuchiya, S., Yamabe, M., Yamaguchi, Y. et al. (1980). Establishment and characterization of a human acute monocytic leukemia cell line (THP-1). International Journal of Cancer 26, 171-6.
16. Seral, C., Michot, J. M., Chanteux, H. et al. (2003). Influence of P-glycoprotein inhibitors on accumulation of macrolides in J774 murine macrophages. Antimicrobial Agents and Chemotherapy 47, 1047-51.
17. Lowry, O. H., Rosebrough, N. J., Farr, A. L. et al. (1951). Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry 193, 265-75.
18. Ouadrhiri, Y., Scorneaux, B., Sibille, Y. et al. (1999). Mechanism of the intracellular killing and modulation of antibiotic susceptibility of Listeria monocytogenes in THP-1 macrophages activated by gamma interferon. Antimicrobial Agents and Chemotherapy 43, 1242-51.
19. Xuan, D., Banevicius, M., Capitano, B. et al. (2002). Pharmacodynamic assessment of ertapenem (MK-0826) against Streptococcus pneumoniae in a murine neutropenic thigh infection model. Antimicrobial Agents and Chemotherapy 46, 2990-5.
20. Foulds, G., Stankewich, J. P., Marshall, D. C. et al. (1983). Pharmacokinetics of sulbactam in humans. Antimicrobial Agents and Chemotherapy 23, 692-9.
21. Dreetz, M., Hamacher, J., Eller, J. et al. (11996). Serum bactericidal activities and comparative pharmacokinetics of meropenem and imipenem - cilastatin. Antimicrobial Agents and Chemotherapy 40, 105-9.
22. Viaene, E., Chanteux, H., Servais, H. et al. (2002). Comparative stability studies of antipseudomonal β-lactams for potential administration through portable elastomeric pumps (home therapy for cystic fibrosis patients) and motor-operated syringes (intensive care units). Antimicrobial Agents and Chemotherapy 46, 2327-32.
23. Majumdar, A. K., Musson, D. G., Birk, K. L. et al. (2002). Pharmacokinetics of ertapenem in healthy young volunteers. Antimicrobial Agents and Chemotherapy 46, 3506-11.
24. Craig, W. A. (2003). Basic pharmacodynamics of antibacterials with clinical applications to the use of β-lactams, glycopeptides, and linezolid. Infectious Disease Clinics of North America 17, 479-501.
25. Giesbrecht, P., Kersten, T., Maidhof, H. et al. (1998). Staphylococcal cell wall: morphogenesis and fatal variations in the presence of penicillin. Microbiology and Molecular Biology Reviews 62, 1371-414.
26. Dalhoff, A., Nasu, T. & Okamoto, K. (2003). Target affinities of faropenem to and its impact on the morphology of gram-positive and gram-negative bacteria. Chemotherapy 49, 172-83.
27. Renard, C., Vanderhaeghe, H. J., Claes, P. J. et al. (1987). Influence of conversion of penicillin G into a basic derivative on its accumulation and subcellular localization in cultured macrophages. Antimicrobial Agents and Chemotherapy 31, 410-6.
28. Kapral, F. A. & Shayegani, M. G. (1959). Intracellular survival of staphylococci. Journal of Experimental Medicine 110, 123-38.
29. Ohkuma, S. & Poole, B. (1978). Fluorescence probe measurement of the intralysosomal pH in living cells and the perturbation of pH by various agents. Proceedings of the National Academy of Sciences, USA 75, 3327-31.
30. Moulder, J. W. (1985). Comparative biology of intracellular parasitism. Microbiological Reviews 49, 298-337.
31. Sanchez, M. S., Ford, C. W. & Yancey, R. J., Jr (1988). Evaluation of antibiotic effectiveness against Staphylococcus aureus surviving within the bovine mammary gland macrophage. Journal of Antimicrobial Chemotherapy 21, 773-86.
32. Scaglione, F., Demartini, G., Dugnani, S. et al. (1993). A new model examining intracellular and extracellular activity of amoxicillin, azithromycin, and clarithromycin in infected cells. Chemotherapy 39, 416-23.
33. Seleznev, A. S. & Bykov, A. S. (1981). Electron microscopic study of the effect of methicillin on phagocytized Staphylococcus aureus cells. Antibiotiki 26, 514-9.
34. van den Broek, P. J. (1989). Antimicrobial drugs, microorganisms, and phagocytes. Reviews of Infectious Diseases 11, 213-45.
35. van den Broek, P. J. (1991). Activity of antibiotics against microorganisms ingested by mononuclear phagocytes. European Journal of Clinical Microbiology and Infectious Diseases 10, 114-8.
36. Paillard, D., Grellet, J., Dubois, V. et al. (2002). Discrepancy between uptake and intracellular activity of moxifloxacin in a Staphylococcus aureus-human THP-1 monocytic cell model. Antimicrobial Agents and Chemotherapy 46, 288-93.